Prophylaxis and Treatment
Here, we will address the dermatologic toxicities associated with Multikinase inhibitor treatment are addressed on this website. This section of the website, ‘Prophylaxis and treatment’, comprises the following sub-sections:
- What healthcare providers should know: The key treatment principles for multikinase inhibitor-related skin toxicities
- What patients can do: The key behavioural and prophylactic measures that can be undertaken by patients to minimise dermatologic side effects
- Prophylactic management: Therapeutic principles which help to minimise the grade and extent of toxicities.
- Reactive management: Information on close monitoring of and early intervention in dermatologic side effects associated with multikinase inhibitors.